A Philosophy for CNS Radiotracer Design-Reference-Cited by-同舟云学术

A Philosophy for CNS Radiotracer Design

Published:2014-10-01 Issue:10 Volume:47 Page:3127-3134
ISSN:0001-4842
Container-title:Accounts of Chemical Research
language:en
Short-container-title:Acc. Chem. Res.

Author:

Van de Bittner Genevieve C.¹,Ricq Emily L.¹²,Hooker Jacob M.¹

Affiliation:

1. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, United States

2. Department of Chemistry and Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, United States

Funder

National Institute on Drug Abuse

Publisher

American Chemical Society (ACS)

Subject

General Medicine,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ar500233s

Reference53 articles.

1. Invasiveness in Studies of Brain Function by Positron Emission Tomography (PET)

2. PET radiotracers for molecular imaging in the brain: Past, present and future

3. Translational PET imaging research

4. CNS Radiotracer Tablehttp://www.nimh.nih.gov/research-priorities/therapeutics/cns-radiotracer-table.shtml(accessed Jun 17, 2014) .

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [18F]RS-127445 radiosynthesis and evaluation as a 5-HT2B receptor PET radiotracer in rat brain;Bioorganic & Medicinal Chemistry Letters;2024-11

2. DESI-TQ-MS imaging for ex vivo brain biodistribution assessment: evaluation of LBT-999, a ligand of the dopamine transporter (DAT);EJNMMI Radiopharmacy and Chemistry;2024-08-27

3. Emerging targets for positron emission tomography imaging in proteinopathies;npj Imaging;2024-08-21

4. Advances and Insights in Positron Emission Tomography Tracers for Metabotropic Glutamate Receptor 4 Imaging;Journal of Medicinal Chemistry;2024-06-26

5. Investigation of imaging the somatostatin receptor by opening the blood-brain barrier with melittin – A feasibility study using positron emission tomography and [64Cu]Cu-DOTATATE;Nuclear Medicine and Biology;2024-05